These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1305 related articles for article (PubMed ID: 17605727)

  • 41. [Invasive fungal infection in malignant hematologic diseases].
    Sinkó J; Csomor J; Nikolova R
    Orv Hetil; 1998 Feb; 139(8):409-12. PubMed ID: 9524423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
    Trifilio S; Singhal S; Williams S; Frankfurt O; Gordon L; Evens A; Winter J; Tallman M; Pi J; Mehta J
    Bone Marrow Transplant; 2007 Sep; 40(5):451-6. PubMed ID: 17589527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
    Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
    Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Alexander BD; Dodds Ashley ES; Addison RM; Alspaugh JA; Chao NJ; Perfect JR
    Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
    Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
    Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Central nervous system aspergillosis in allogeneic stem cell transplant recipients.
    Jantunen E; Volin L; Salonen O; Piilonen A; Parkkali T; Anttila VJ; Paetau A; Ruutu T
    Bone Marrow Transplant; 2003 Feb; 31(3):191-6. PubMed ID: 12621480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
    Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
    J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999.
    Lortholary O; Charlemagne A; Bastides F; Chevalier P; Datry A; Gonzalves MF; Michel G; Tilleul P; Veber B; Herbrecht R
    J Antimicrob Chemother; 2004 Aug; 54(2):456-64. PubMed ID: 15231769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience.
    Crassard N; Hadden H; Pondarré C; Hadden R; Galambrun C; Piens MA; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
    Transpl Infect Dis; 2008 Jun; 10(3):177-83. PubMed ID: 18331389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience.
    Zhang P; Jiang EL; Yang DL; Yan ZS; Huang Y; Wei JL; Wang M; Ma QL; Liu QG; Zou DH; He Y; Qiu LG; Feng SZ; Han MZ
    Transpl Infect Dis; 2010 Aug; 12(4):316-21. PubMed ID: 20180926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation.
    Safdar A; Rodriguez G; Ohmagari N; Kontoyiannis DP; Rolston KV; Raad II; Champlin RE
    Cancer; 2005 Feb; 103(4):731-9. PubMed ID: 15641032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
    Husain S; Alexander BD; Munoz P; Avery RK; Houston S; Pruett T; Jacobs R; Dominguez EA; Tollemar JG; Baumgarten K; Yu CM; Wagener MM; Linden P; Kusne S; Singh N
    Clin Infect Dis; 2003 Jul; 37(2):221-9. PubMed ID: 12856215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New approaches to invasive fungal infections in acute leukemia and hematopoietic stem cell transplant patients.
    Wingard JR
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):99-107. PubMed ID: 17336260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis.
    Reichenberger F; Habicht J; Matt P; Frei R; Solèr M; Bolliger CT; Dalquen P; Gratwohl A; Tamm M
    Bone Marrow Transplant; 1999 Dec; 24(11):1195-9. PubMed ID: 10642808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
    Cordonnier C; Bresnik M; Ebrahimi R
    Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients.
    Cordonnier C; Maury S; Pautas C; Bastié JN; Chehata S; Castaigne S; Kuentz M; Bretagne S; Ribaud P
    Bone Marrow Transplant; 2004 May; 33(9):943-8. PubMed ID: 15034546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
    Rogers TR; Frost S
    Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
    Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
    Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fungal infections in the immunocompromised host.
    Hawkins C; Armstrong D
    Clin Haematol; 1984 Oct; 13(3):599-630. PubMed ID: 6388935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allogeneic hematopoietic stem cell transplantation after surgical resection of pulmonary aspergillosis in 5 patients with acute leukemia.
    Motohashi K; Ito S; Hagihara M; Sakai R; Tanaka M; Kawano T; Maruta A; Ishigatsubo Y; Kanamori H
    Rinsho Ketsueki; 2009 May; 50(5):430-4. PubMed ID: 19483405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.